Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Plastic Chip Identifies DNA Sequences in Drop of Blood

By LabMedica International staff writers
Posted on 09 May 2012
A small plastic chip developed using nanotechnology can determine whether a patient is resistant to cancer drugs or has diseases such as malaria. More...
The chip can also pinpoint infectious diseases in a herd of cattle.

The technology that uses the plastic chip can perform 20 genetic tests from a single drop of blood. The innovation has earned Aquila Diagnostic Systems (Edmonton, Canada), a finalist nod for this year’s TEC (Edmonton, Canada) NanoVenturePrize award. Aquila Diagnostics is a nano startup originating from the University of Alberta (U of A; Edmonton, Canada).

Dubbed the Domino technology, it employs miniaturized polymerase chain reaction (PCR) technology to amplify and detect targeted sequences of DNA in a form that fits on a plastic chip the size of two postage stamps. The chip contains 20 gel posts--each the size of a pinhead--capable of identifying sequences of DNA in a single drop of blood. The Domino has been used in several recently published studies, showing similar accuracy to centralized labs.

A metal cube the size of a toaster, with the small plastic chip at its core, created at the University of Alberta is capable of performing the same genetic tests as most fully equipped modern laboratories--and in a fraction of the time. Along with its versatility, two key selling points are affordability and portability, with each portable box expected to cost about USD 5,000 and each chip a few dollars, according to Aquila president David Alton. It is also designed to be easy to use and rugged for use in the field.

Each post performs its own genetic test, meaning that it is possible not only to find out whether an individual has malaria, but also to determine the type of malaria and whether the person’s DNA makes him resistant to certain antimalarial drugs. It takes less than an hour to process one chip, making it possible to screen large populations in a short time.

“We [are] basically replacing millions of dollars of equipment in a conventional, consolidated lab with something that costs pennies to produce and is field portable so that it can be taken where needed. That [is] where this technology shines,” said Jason Acker, an associate professor of laboratory medicine and pathology at the University of Alberta and chief technology officer with Aquila.

Aquila’s relationship with the U of A and its business relationship with TEC Edmonton helped the company to license and patent Domino. TEC Edmonton is a joint venture between the U of A and Edmonton Economic Development Corp. It has resources and expertise to help startups in the early stages of operations.

Related Links:

Aquila Diagnostic Systems
TEC
University of Alberta



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.